Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Huge News for Hims & Hers Stock


Hims Hers (NYSE: HIMS) is adding another specialty in an effort to build out its healthcare platform. The company has brought testosterone to the market, the first big addition since weight loss in 2023. This is the kind of move that could drive the company's growth, which Travis Hoium highlights in this video.

*Stock prices used were end-of-day prices of Sept. 10, 2025. The video was published on Sept. 11, 2025.

Continue reading


Source Fool.com

Like: 0
Share

Comments